arrow
S

Seiichi Imanishi

Department of Breast Surgery
H指数:7
被引数:204

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Validation of the predictive ability for recurrence and the clinical utility of the 95-gene classifier (95GC) through an integrated analysis of five studies

通过五项研究的综合分析验证95-gene classifier(95GC)对复发的预测能力及其临床应用价值

2025-06-250
PRE
Docetaxel, cyclophosphamide, and trastuzumab as neoadjuvant chemotherapy for HER2-positive primary breast cancer
2016-02-1311
PREAI